Trial Milestone Reached; UK-Based Biopharma Gets $15 Million – Streetwise Reports

Trial Milestone Reached; UK-Based Biopharma Gets $15 Million – Streetwise Reports
Trial Milestone Reached; UK-Based Biopharma Gets $15 Million  Streetwise ReportsThe first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. ... read more
Source: Google NewsPublished on 2019-05-08